Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer,
occurrence of cancer, or patient outcome. They may include germline or somatic genetic …

With the availability of new technologies and the increased interest of medical practitioners
to use molecular biomarkers in early detection and diagnosis, and in the prediction of …

Biomarkers are molecular indicators of a biological status, and as biochemical species can
be assayed to evaluate the presence of cancer and therapeutic interventions. Through a …

Cancer is a group of diseases characterized by the uncontrolled growth and spread of
abnormal cells and oncology is a branch of medicine that deals with tumors. The last decade …

Cancer is generally caused by the molecular alterations which lead to specific mutations.
Advances in molecular biology have provided an impetus to the study of cancers with …

Cancer is one of the major public health problems worldwide representing the leading
cause of morbidity and mortality in industrialized countries. To reduce cancer morbidity and …

Biomarkers provide a powerful and dynamic approach to understanding the spectrum of
malignancies with applications in observational and analytic epidemiology, randomized …

Biomarkers have many potential applications in oncology, including risk assessment,
screening, differential diagnosis, determination of prognosis, prediction of response to …

Diagnostic detection and measurement of cancer disease progression are essential
elements for successful cancer disease management. The early stages of cancer …

Advances in genomics, proteomics and molecular pathology have generated many
candidate biomarkers with potential clinical value. Their use for cancer staging and …